| Product NDC: | 0781-5325 |
| Proprietary Name: | Bromocriptine mesylate |
| Non Proprietary Name: | Bromocriptine mesylate |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; Bromocriptine mesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0781-5325 |
| Labeler Name: | Sandoz Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074631 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19980113 |
| Package NDC: | 0781-5325-31 |
| Package Description: | 30 TABLET in 1 BOTTLE (0781-5325-31) |
| NDC Code | 0781-5325-31 |
| Proprietary Name | Bromocriptine mesylate |
| Package Description | 30 TABLET in 1 BOTTLE (0781-5325-31) |
| Product NDC | 0781-5325 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bromocriptine mesylate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19980113 |
| Marketing Category Name | ANDA |
| Labeler Name | Sandoz Inc |
| Substance Name | BROMOCRIPTINE MESYLATE |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |